Title : Identification of a synergistic combination of Smac mimetic and Bortezomib to trigger cell death in B-cell non-Hodgkin lymphoma cells.

Pub. Date : 2017 Oct 1

PMID : 28716527






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Consistently, BV6/Bortezomib co-treatment alone or in combination with zVAD.fmk increases phosphorylation of MLKL, a typical marker of necroptosis. benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone mixed lineage kinase domain like pseudokinase Homo sapiens
2 Similarly, pharmacological inhibitors of MLKL (i.e. NSA), RIP3 (i.e. GSK"872, Dabrafenib) or RIP1 (i.e. Necrostatin-1s) significantly rescue DG-75 cells from BV6/Bortezomib-induced cell death irrespective of the presence of zVAD.fmk. benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone mixed lineage kinase domain like pseudokinase Homo sapiens